Indivior Pharmaceuticals, Inc.

NSDQHealth care

Last traded price · USD

$36.41

+2.94%Delayed · Pre-market

Delayed 15 minutes · Source: ViewTrade · 3 Nov 2026, 05:36 IST · A quote does not mean the product is available to trade on your account.

Day's open: —
Previous close: $35.37
Volume: 4.9M
Day's high: —
Day's low: —

In brief

Indivior Pharmaceuticals, Inc. is a health care company listed on Nasdaq, valued at about $4.30B.
From India you can buy INDV in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy Indivior Pharmaceuticals, Inc. (INDV) shares from India?

Yes. Indian residents can invest in the US stock market under the Reserve Bank of India's Liberalised Remittance Scheme (LRS), which lets a resident individual remit up to USD 250,000 per financial year, across all permitted purposes combined. US-listed stocks and ETFs are a permitted investment under the LRS. You are solely responsible for ensuring your remittances comply with the LRS annual limit, the applicable Tax Collected at Source (TCS) rules, and all reporting requirements, including Schedule FA in your income-tax return.

Do I need the price of a whole INDV share to invest?

Yes. You can buy fractional shares, which lets you invest a fixed rupee/dollar amount even in high-priced stocks. For example, if one share trades at USD 1,000 and you invest USD 100, you receive 0.1 of a share.

How much can I invest in US stocks in a year?

Under the LRS, an Indian resident can remit up to USD 250,000 per financial year (April to March) across all permitted purposes combined, from their own funds. This is a per-individual limit set by the RBI.

Can I trade INDV options or futures?

No. Under RBI / FEMA rules, the LRS does not permit margin trading or speculative instruments such as futures, options, or other derivatives. Your US account is a cash account, not a derivatives and margin account.

Insights

Quotes run fifteen minutes behind.

9.4M shares sold short
9.4M shares were sold short at the 15 Oct 2026 settlement; covering them would take 3.4 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026

Returns

Price return, split-adjusted

1 month—

6 months—

1 year—

5 years—

Newswire

About

Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).

Website

Indivior Pharmaceuticals, Inc.

NSDQHealth care

Last traded price · USD

$36.41

+2.94%Delayed · Pre-market

Delayed 15 minutes · Source: ViewTrade · 3 Nov 2026, 05:36 IST · A quote does not mean the product is available to trade on your account.

Day's open: —
Previous close: $35.37
Volume: 4.9M
Day's high: —
Day's low: —

In brief

Indivior Pharmaceuticals, Inc. is a health care company listed on Nasdaq, valued at about $4.30B.
From India you can buy INDV in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy Indivior Pharmaceuticals, Inc. (INDV) shares from India?

Do I need the price of a whole INDV share to invest?

How much can I invest in US stocks in a year?

Can I trade INDV options or futures?

Insights

Quotes run fifteen minutes behind.

9.4M shares sold short
9.4M shares were sold short at the 15 Oct 2026 settlement; covering them would take 3.4 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026

Returns

Price return, split-adjusted

1 month—

6 months—

1 year—

5 years—

Newswire

About

Website

Indivior Pharmaceuticals, Inc.

Indivior Pharmaceuticals, Inc. in brief

9.4M shares sold short

Indivior Pharmaceuticals, Inc.

Indivior Pharmaceuticals, Inc. in brief

9.4M shares sold short